Data Quality Assurance and Statistical Analysis of High Throughput Screenings for Drug Discovery
暂无分享,去创建一个
Yang Zhong | Jianwei Che | Zuojun Guo | Zuojun Guo | Jianwei Che | Yang Zhong | Zuojun Guo
[1] Fabio Gasparri,et al. An overview of cell phenotypes in HCS: limitations and advantages , 2009, Expert opinion on drug discovery.
[2] Paul Labute,et al. A probabilistic approach to high throughput drug discovery. , 2002, Combinatorial chemistry & high throughput screening.
[3] Tudor I. Oprea,et al. Pursuing the leadlikeness concept in pharmaceutical research. , 2004, Current opinion in chemical biology.
[4] R. König,et al. A probability-based approach for the analysis of large-scale RNAi screens , 2007, Nature Methods.
[5] Meir Glick,et al. Enrichment of Extremely Noisy High-Throughput Screening Data Using a Naïve Bayes Classifier , 2004, Journal of biomolecular screening.
[6] Kaisheng Chen,et al. In silico gene function prediction using ontology-based pattern identification , 2005, Bioinform..
[7] Bert Gunter,et al. Statistical and Graphical Methods for Quality Control Determination of High-Throughput Screening Data , 2003, Journal of biomolecular screening.
[8] Meir Glick,et al. Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases , 2006, J. Chem. Inf. Model..
[9] B. Shoichet. Screening in a spirit haunted world. , 2006, Drug discovery today.
[10] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[11] Robert Nadon,et al. An efficient method for the detection and elimination of systematic error in high-throughput screening , 2007, Bioinform..
[12] Xiaohua Douglas Zhang. A pair of new statistical parameters for quality control in RNA interference high-throughput screening assays. , 2007, Genomics.
[13] Wolfgang Huber,et al. Analysis of cell-based RNAi screens , 2006, Genome Biology.
[14] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[15] David B Volkin,et al. Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies. , 2011, Journal of pharmaceutical sciences.
[16] T. Bayes. An essay towards solving a problem in the doctrine of chances , 2003 .
[17] Isabel Coma,et al. Statistics and decision making in high-throughput screening. , 2009, Methods in molecular biology.
[18] Jörg Hüser,et al. High‐throughput Screening for Targeted Lead Discovery , 2006 .
[19] Frank K Brown,et al. Practical Approaches to Efficient Screening: Information-Rich Screening Protocol , 2004, Journal of biomolecular screening.
[20] Xiaoyang Xia,et al. Classification of kinase inhibitors using a Bayesian model. , 2004, Journal of medicinal chemistry.
[21] Yingyao Zhou,et al. The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontology-based pattern identification. , 2005, Molecular and biochemical parasitology.
[22] Amy S. Espeseth,et al. Host Cell Factors in HIV Replication: Meta-Analysis of Genome-Wide Studies , 2009, PLoS pathogens.
[23] M F Engels,et al. Smart screening: approaches to efficient HTS. , 2001, Current opinion in drug discovery & development.
[24] W. Aird,et al. Robo4 is an effective tumor endothelial marker for antibody-drug conjugates based on the rapid isolation of the anti-Robo4 cell-internalizing antibody. , 2013, Blood.
[25] Richard Simon,et al. A random variance model for detection of differential gene expression in small microarray experiments , 2003, Bioinform..
[26] Xiaohua Douglas Zhang,et al. An Effective Method for Controlling False Discovery and False Nondiscovery Rates in Genome-Scale RNAi Screens , 2010, Journal of biomolecular screening.
[27] Tudor I. Oprea,et al. Post-High-Throughput Screening Analysis: An Empirical Compound Prioritization Scheme , 2005, Journal of biomolecular screening.
[28] E. Schadt,et al. Integrating siRNA and protein-protein interaction data to identify an expanded insulin signaling network. , 2009, Genome research.
[29] Bin Chen,et al. Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis , 2009, J. Chem. Inf. Model..
[30] Marc Ferrer,et al. Robust statistical methods for hit selection in RNA interference high-throughput screening experiments. , 2006, Pharmacogenomics.
[31] Gavin Harper,et al. Process Validation and Screen Reproducibility in High-Throughput Screening , 2009, Journal of biomolecular screening.
[32] C. Moallemi,et al. Quantized surface complementarity diversity (QSCD): a model based on small molecule-target complementarity. , 2000, Journal of medicinal chemistry.
[33] Francisco-Javier Gamo,et al. Global phenotypic screening for antimalarials. , 2012, Chemistry & biology.
[34] Alexander Alanine,et al. Lead generation--enhancing the success of drug discovery by investing in the hit to lead process. , 2003, Combinatorial chemistry & high throughput screening.
[35] Hans-Joachim Böhm,et al. A guide to drug discovery: Hit and lead generation: beyond high-throughput screening , 2003, Nature Reviews Drug Discovery.
[36] D. Swinney,et al. How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.
[37] A. Hill,et al. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves , 1910 .
[38] Paul A Johnston,et al. Identifying Actives from HTS Data Sets , 2011, Journal of biomolecular screening.
[39] Christopher P Austin,et al. High-throughput screening assays for the identification of chemical probes. , 2007, Nature chemical biology.
[40] F. Hampel. A General Qualitative Definition of Robustness , 1971 .
[41] K. Horiuchi,et al. Innovative chemical compound microarrays for drug screening , 2006 .
[42] Stuart L. Schreiber,et al. Identifying Biologically Active Compound Classes Using Phenotypic Screening Data and Sampling Statistics , 2005, J. Chem. Inf. Model..
[43] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[44] L. Makings,et al. A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases. , 2002, Assay and drug development technologies.
[45] Xiaohua Douglas Zhang,et al. Illustration of SSMD, z Score, SSMD*, z* Score, and t Statistic for Hit Selection in RNAi High-Throughput Screens , 2011, Journal of biomolecular screening.
[46] Linda O Narhi,et al. High-throughput assessment of thermal and colloidal stability parameters for monoclonal antibody formulations. , 2011, Journal of pharmaceutical sciences.
[47] Eero P. Simoncelli,et al. Nonlinear image representation for efficient perceptual coding , 2006, IEEE Transactions on Image Processing.
[48] Jeffrey E. Lee,et al. Generation of Monoclonal Antibody MS17-57 Targeting Secreted Alkaline Phosphatase Ectopically Expressed on the Surface of Gastrointestinal Cancer Cells , 2013, PloS one.
[49] D. Bojanic,et al. Impact of high-throughput screening in biomedical research , 2011, Nature Reviews Drug Discovery.
[50] Andreas Bender,et al. Understanding False Positives in Reporter Gene Assays: in Silico Chemogenomics Approaches To Prioritize Cell-Based HTS Data , 2007, J. Chem. Inf. Model..
[51] Xiaohua Douglas Zhang. Genome-wide screens for effective siRNAs through assessing the size of siRNA effects , 2008 .
[52] Amy M. Wiles,et al. An Analysis of Normalization Methods for Drosophila RNAi Genomic Screens and Development of a Robust Validation Scheme , 2008, Journal of biomolecular screening.
[53] D. Rogers,et al. Using Extended-Connectivity Fingerprints with Laplacian-Modified Bayesian Analysis in High-Throughput Screening Follow-Up , 2005, Journal of biomolecular screening.
[54] Xiaohua Douglas Zhang,et al. Determination of sample size in genome-scale RNAi screens , 2009, Bioinform..
[55] Noel Southall,et al. COPI Complex Is a Regulator of Lipid Homeostasis , 2008, PLoS biology.
[56] Gary Walker,et al. Enhancing Hit Quality and Diversity within Assay Throughput Constraints , 2005 .
[57] Anthony E. Klon,et al. Improved Naïve Bayesian Modeling of Numerical Data for Absorption, Distribution, Metabolism and Excretion (ADME) Property Prediction , 2006, J. Chem. Inf. Model..
[58] W. Patrick Walters,et al. A guide to drug discovery: Designing screens: how to make your hits a hit , 2003, Nature Reviews Drug Discovery.
[59] Hanspeter Gubler,et al. Methods for Statistical Analysis, Quality Assurance and Management of Primary High‐throughput Screening Data , 2006 .
[60] Bert Gunter,et al. Improved Statistical Methods for Hit Selection in High-Throughput Screening , 2003, Journal of biomolecular screening.
[61] Hans-Jörg Roth,et al. There is no such thing as 'diversity'! , 2005, Current opinion in chemical biology.
[62] J. Baell,et al. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.
[63] Xiaohua Douglas Zhang,et al. A New Method with Flexible and Balanced Control of False Negatives and False Positives for Hit Selection in RNA Interference High-Throughput Screening Assays , 2007, Journal of biomolecular screening.
[64] Andreas Sewing,et al. Evaluating Real-Life High-Throughput Screening Data , 2005, Journal of biomolecular screening.
[65] A. Weaver,et al. Freshwater Forcing: Will History Repeat Itself? , 2008, Science.
[66] Paul Labute,et al. Binary QSAR: A New Method for the Determination of Quantitative Structure Activity Relationships , 1998, Pacific Symposium on Biocomputing.
[67] David E Root,et al. Detecting Spatial Patterns in Biological Array Experiments , 2003, Journal of biomolecular screening.
[68] David G. Lambert,et al. Drugs and receptors , 2004 .
[69] Robert Nadon,et al. Statistical practice in high-throughput screening data analysis , 2006, Nature Biotechnology.
[70] James Inglese,et al. Apparent activity in high-throughput screening: origins of compound-dependent assay interference. , 2010, Current opinion in chemical biology.
[71] Marc Ferrer,et al. Median Absolute Deviation to Improve Hit Selection for Genome-Scale RNAi Screens , 2008, Journal of biomolecular screening.
[72] Peter Sommer,et al. A novel specific edge effect correction method for RNA interference screenings , 2012, Bioinform..
[73] D. Pereira,et al. Origin and evolution of high throughput screening , 2007, British journal of pharmacology.
[74] C. Brenan,et al. Nanoliter high-throughput PCR for DNA and RNA profiling. , 2009, Methods in molecular biology.
[75] V. Socci,et al. Design and validation of siRNAs and shRNAs. , 2009, Current opinion in molecular therapeutics.
[76] Christopher P Austin,et al. A high-throughput screen for aggregation-based inhibition in a large compound library. , 2007, Journal of medicinal chemistry.
[77] Xiaohua Douglas Zhang,et al. A method for effectively comparing gene effects in multiple conditions in RNAi and expression-profiling research. , 2009, Pharmacogenomics.
[78] S Stanley Young,et al. Using recursive partitioning analysis to evaluate compound selection methods. , 2004, Methods in molecular biology.
[79] Dongmei Liu,et al. Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings. , 2008, Journal of biomolecular screening.
[80] Lorenz M Mayr,et al. Novel trends in high-throughput screening. , 2009, Current opinion in pharmacology.
[81] Winston A Hide,et al. Big data: The future of biocuration , 2008, Nature.
[82] M. Gerstein,et al. Unlocking the secrets of the genome , 2009, Nature.
[83] B. Shoichet,et al. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.
[84] Aideen Long,et al. Statistical methods for analysis of high-throughput RNA interference screens , 2009, Nature Methods.
[85] Paul T. Groth,et al. The ENCODE (ENCyclopedia Of DNA Elements) Project , 2004, Science.
[86] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[87] Anne Mai Wassermann,et al. Biodiversity of small molecules--a new perspective in screening set selection. , 2013, Drug discovery today.
[88] Stephen D. Pickett,et al. Research Papers) Design of a Compound Screening Collection for use in High Throughput Screening , 2004 .
[89] B. Shoichet,et al. A specific mechanism of nonspecific inhibition. , 2003, Journal of medicinal chemistry.
[90] T. Keating,et al. Correction for Interference by Test Samples in High-Throughput Assays , 2009, Journal of biomolecular screening.
[91] Yanli Wang,et al. A novel method for mining highly imbalanced high-throughput screening data in PubChem , 2009, Bioinform..
[92] V. Makarenkov,et al. Statistical Analysis of Systematic Errors in High-Throughput Screening , 2005, Journal of biomolecular screening.
[93] Sanjay Joshua Swamidass,et al. Enhancing the rate of scaffold discovery with diversity-oriented prioritization , 2011, Bioinform..
[94] Adam Yasgar,et al. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[95] C. Bakal,et al. Phosphorylation Networks Regulating JNK Activity in Diverse Genetic Backgrounds , 2008, Science.
[96] C. Bakal,et al. Genomic screening with RNAi: results and challenges. , 2010, Annual review of biochemistry.
[97] Bin Zhou,et al. Chemical and Biological Properties of Frequent Screening Hits , 2012, J. Chem. Inf. Model..
[98] Jing Li,et al. Novel Statistical Approach for Primary High-Throughput Screening Hit Selection , 2005, J. Chem. Inf. Model..
[99] David E Root,et al. A flexible data analysis tool for chemical genetic screens. , 2004, Chemistry & biology.
[100] William Stafford Noble,et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.
[101] B. Shoichet,et al. High-throughput assays for promiscuous inhibitors , 2005, Nature chemical biology.
[102] Ricardo Macarrón,et al. Design and Implementation of High Throughput Screening Assays , 2011, Molecular biotechnology.
[103] Ramm,et al. Imaging systems in assay screening. , 1999, Drug discovery today.
[104] Marc Ferrer,et al. The Use of SSMD-Based False Discovery and False Nondiscovery Rates in Genome-Scale RNAi Screens , 2010, Journal of biomolecular screening.
[105] Kristin E. D. Coan,et al. Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding , 2009, Journal of medicinal chemistry.
[106] Peter J. Rousseeuw,et al. Robust Distances: Simulations and Cutoff Values , 1991 .
[107] Andreas Bender,et al. “Plate Cherry Picking”: A Novel Semi-Sequential Screening Paradigm for Cheaper, Faster, Information-Rich Compound Selection , 2007, Journal of biomolecular screening.
[108] S A Sundberg,et al. High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. , 2000, Current opinion in biotechnology.
[109] Yanli Wang,et al. PubChem BioAssay: 2014 update , 2013, Nucleic Acids Res..
[110] Thomas D. Y. Chung,et al. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.
[111] Jürgen Bajorath,et al. Polypharmacology Directed Compound Data Mining: Identification of Promiscuous Chemotypes with Different Activity Profiles and Comparison to Approved Drugs , 2010, J. Chem. Inf. Model..
[112] N. Perrimon,et al. Genome-Wide RNAi Analysis of Growth and Viability in Drosophila Cells , 2004, Science.
[113] Meir Glick,et al. Streamlining lead discovery by aligning in silico and high-throughput screening. , 2006, Current opinion in chemical biology.
[114] Christopher P Austin,et al. Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. , 2010, Journal of medicinal chemistry.
[115] Lorenz M Mayr,et al. The Future of High-Throughput Screening , 2008, Journal of biomolecular screening.
[116] Christian N. Parker,et al. Application of Chemoinformatics to High-Throughput Screening , 2004 .
[117] S Stanley Young,et al. Initial compound selection for sequential screening. , 2002, Current opinion in drug discovery & development.
[118] Mohammad Fallahi-Sichani,et al. Metrics other than potency reveal systematic variation in responses to cancer drugs. , 2013, Nature chemical biology.
[119] Lirong Chen,et al. Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells , 2004, Journal of Virology.
[120] Jing Liu,et al. Experimental Design and Statistical Methods for Improved Hit Detection in High-Throughput Screening , 2010, Journal of biomolecular screening.
[121] Anthony E. Klon,et al. Library Fingerprints: A Novel Approach to the Screening of Virtual Libraries , 2007, J. Chem. Inf. Model..
[122] Robert Nadon,et al. Systematic error detection in experimental high-throughput screening , 2011, BMC Bioinformatics.
[123] Andrew I Su,et al. HierS: hierarchical scaffold clustering using topological chemical graphs. , 2005, Journal of medicinal chemistry.
[124] Min Xu,et al. Hit selection with false discovery rate control in genome-scale RNAi screens , 2008, Nucleic acids research.